Literature DB >> 18301096

Case-control study of lung cancer risk from residential radon exposure in Worcester county, Massachusetts.

Richard E Thompson1, Donald F Nelson, Joel H Popkin, Zenaida Popkin.   

Abstract

A study of lung cancer risk from residential radon exposure and its radioactive progeny was performed with 200 cases (58% male, 42% female) and 397 controls matched on age and sex, all from the same health maintenance organization. Emphasis was placed on accurate and extensive year-long dosimetry with etch-track detectors in conjunction with careful questioning about historic patterns of in-home mobility. Conditional logistic regression was used to model the outcome of cancer on radon exposure, while controlling for years of residency, smoking, education, income, and years of job exposure to known or potential carcinogens. Smoking was accounted for by nine categories: never smokers, four categories of current smokers, and four categories of former smokers. Radon exposure was divided into six categories (model 1) with break points at 25, 50, 75, 150, and 250 Bq m, the lowest being the reference. Surprisingly, the adjusted odds ratios (AORs) were, in order, 1.00, 0.53, 0.31, 0.47, 0.22, and 2.50 with the third category significantly below 1.0 (p < 0.05), and the second, fourth, and fifth categories approaching statistical significance (p < 0.1). An alternate analysis (model 2) using natural cubic splines allowed calculating AORs as a continuous function of radon exposure. That analysis produces AORs that are substantially less than 1.0 with borderline statistical significance (0.048 < or = p < or = 0.05) between approximately 85 and 123 Bq m. College-educated subjects in comparison to high-school dropouts have a significant reduction in cancer risk after controlling for smoking, years of residency, and job exposures with AOR = 0.30 (95% CI: 0.13, 0.69), p = 0.005 (model 1).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18301096     DOI: 10.1097/01.HP.0000288561.53790.5f

Source DB:  PubMed          Journal:  Health Phys        ISSN: 0017-9078            Impact factor:   1.316


  28 in total

Review 1.  Radon in indoor spaces: an underestimated risk factor for lung cancer in environmental medicine.

Authors:  Klaus Schmid; Torsten Kuwert; Hans Drexler
Journal:  Dtsch Arztebl Int       Date:  2010-03-19       Impact factor: 5.594

2.  The healthy worker effect and nuclear industry workers.

Authors:  Krzysztof W Fornalski; Ludwik Dobrzyński
Journal:  Dose Response       Date:  2010-01-06       Impact factor: 2.658

3.  Special issue introduction.

Authors:  Bobby R Scott
Journal:  Dose Response       Date:  2010-01-04       Impact factor: 2.658

4.  Epidemiological Evidence for Possible Radiation Hormesis from Radon Exposure: A Case-Control Study Conducted in Worcester, MA.

Authors:  Richard E Thompson
Journal:  Dose Response       Date:  2010-12-14       Impact factor: 2.658

5.  Meta-analysis of case-control studies on the relationship between lung cancer and indoor radon exposure.

Authors:  Georgy Malinovsky; Ilia Yarmoshenko; Aleksey Vasilyev
Journal:  Radiat Environ Biophys       Date:  2018-12-08       Impact factor: 1.925

6.  Potential treatment of inflammatory and proliferative diseases by ultra-low doses of ionizing radiations.

Authors:  Charles L Sanders
Journal:  Dose Response       Date:  2012-10-09       Impact factor: 2.658

7.  Radiation hormesis: historical perspective and implications for low-dose cancer risk assessment.

Authors:  Alexander M Vaiserman
Journal:  Dose Response       Date:  2010-01-18       Impact factor: 2.658

8.  Residential radon appears to prevent lung cancer.

Authors:  Bobby R Scott
Journal:  Dose Response       Date:  2011-10-14       Impact factor: 2.658

Review 9.  Ionizing radiation and aging: rejuvenating an old idea.

Authors:  Richard B Richardson
Journal:  Aging (Albany NY)       Date:  2009-11-17       Impact factor: 5.682

10.  Geographical clustering of lung cancer in the province of Lecce, Italy: 1992-2001.

Authors:  Massimo Bilancia; Alessandro Fedespina
Journal:  Int J Health Geogr       Date:  2009-07-01       Impact factor: 3.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.